ConductScience.org, home

Paper · 26933913

Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.

Shi H and 8 others. Oncotarget, 2016. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma. Papers, record 26933913. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26933913

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma.
PubMed
Journal
Oncotarget
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2022-03-17
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shi HHao
2Chen JJian
3Li YYuncheng
4Li GGuojun
5Zhong RRong
6Du DDandan
7Meng RRuiwei
8Kong WWeijia
9Lu MMeixia

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Carcinoma, Squamous CellMajor topic
Gene Expression ProfilingMajor topic
Head and Neck NeoplasmsMajor topic
MicroRNAsMajor topic
Aged
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Prognosis
ROC Curve

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,950,115Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.Cancer Biol Ther2015https://conductscience.org/library/papers/25950115PubMed
219,901,002MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.Carcinogenesis2009https://conductscience.org/library/papers/19901002PubMed
325,575,813Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.Oncotarget2015https://conductscience.org/library/papers/25575813PubMed
425,043,310MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.Oncogene2015https://conductscience.org/library/papers/25043310PubMed
512,809,600Mechanisms of TGF-beta signaling from cell membrane to the nucleus.Cell2003https://conductscience.org/library/papers/12809600PubMed
620,194,856Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.J Clin Oncol2010https://conductscience.org/library/papers/20194856PubMed
719,910,308edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.Bioinformatics2010https://conductscience.org/library/papers/19910308PubMed
822,425,712Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.Oral Oncol2012https://conductscience.org/library/papers/22425712PubMed
924,682,952MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.Tumour Biol2014https://conductscience.org/library/papers/24682952PubMed
1021,304,530The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.Br J Cancer2011https://conductscience.org/library/papers/21304530PubMed

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
41,487,403Molecular mechanisms of human papillomavirus-induced tongue carcinogenesis: A systematic review.J Oral Biol Craniofac Res2026https://conductscience.org/library/papers/41487403PubMed
35,985,767Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer.Aging (Albany NY)2022https://conductscience.org/library/papers/35985767PubMed
35,897,831Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.Int J Mol Sci2022https://conductscience.org/library/papers/35897831PubMed
31,988,797Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures.Cancers Head Neck2020https://conductscience.org/library/papers/31988797PubMed
31,251,108miRBaseMiner, a tool for investigating miRBase content.RNA Biol2019https://conductscience.org/library/papers/31251108PubMed
31,115,550Differential gene methylation patterns in cancerous and non‑cancerous cells.Oncol Rep2019https://conductscience.org/library/papers/31115550PubMed
29,896,284Development Of A Three-Gene Prognostic Signature For Hepatitis B Virus Associated Hepatocellular Carcinoma Based On Integrated Transcriptomic Analysis.J Cancer2018https://conductscience.org/library/papers/29896284PubMed
29,713,196Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma.Cancer Manag Res2018https://conductscience.org/library/papers/29713196PubMed
29,545,878
MicroRNA-let-7e regulates the progression and development of allergic rhinitis by targeting suppressor of cytokine signaling 4 and activating Janus kinase 1/signal transducer and activator of transcription 3 pathway.
Exp Ther Med2018https://conductscience.org/library/papers/29545878PubMed
29,130,107A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.Oncol Rep2017https://conductscience.org/library/papers/29130107PubMed

1 to 10 of 16

See all 16 cited by

Genes31

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26933913

GET https://conductscience.org/api/papers/v1/26933913/references?page=2